Clemens O Hanemann (C Oliver Hanemann)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Obsessive Compulsive Disorder

Histone Deacetylase

Top Venues

Acta neuropathologica communications

Amyotrophic lateral sclerosis & frontotemporal degeneration

This page only lists publications with an associated author ORCID identifier.

Publications

Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, Clemens O Hanemann, Matthias E Futschik, Torsten Bossing, Claudia S Barros
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth. EMBO reports 25 (1) (2024)
Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, Clemens O Hanemann, Matthias E Futschik, Torsten Bossing, Claudia S Barros
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth. EMBO reports 25 (1) (2024)
Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, Clemens O Hanemann, Matthias E Futschik, Torsten Bossing, Claudia S Barros
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth. EMBO reports (2024)
Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, Clemens O Hanemann, Matthias E Futschik, Torsten Bossing, Claudia S Barros
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth. EMBO reports 25 (1) (2024)
Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, Clemens O Hanemann, Matthias E Futschik, Torsten Bossing, Claudia S Barros
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth. EMBO reports 25 (1) (2024)
Foram Dave, Kevin Herrera, Alex Lockley, Laurien L van de Weijer, Summer Henderson, Agbolahan A Sofela, Laura Hook, Claire L Adams, Emanuela Ercolano, David A Hilton, Emmanuel A Maze, Kathreena M Kurian, Sylwia Ammoun, Clemens O Hanemann
Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours. Oncogene (2024)
Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, Clemens O Hanemann, Matthias E Futschik, Torsten Bossing, Claudia S Barros
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth. EMBO reports 25 (1) (2024)
Laurien L van de Weijer, Emanuela Ercolano, Ting Zhang, Maryam Shah, Matthew C Banton, Juri Na, Claire L Adams, David Hilton, Kathreena M Kurian, Clemens O Hanemann
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas. Acta neuropathologica communications 11 (1) (2023)
Laurien L van de Weijer, Emanuela Ercolano, Ting Zhang, Maryam Shah, Matthew C Banton, Juri Na, Claire L Adams, David Hilton, Kathreena M Kurian, Clemens O Hanemann
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas. Acta neuropathologica communications 11 (1) (2023)
Laurien L van de Weijer, Emanuela Ercolano, Ting Zhang, Maryam Shah, Matthew C Banton, Juri Na, Claire L Adams, David Hilton, Kathreena M Kurian, Clemens O Hanemann
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas. Acta neuropathologica communications 11 (1) (2023)
Tessa Kliest, Ruben P A Van Eijk, Ammar Al Chalabi, Alberto Albanese, Peter M Andersen, Maria Del Mar Amador, Geir BrÅthen, Veronique Brunaud-Danel, Lev Brylev, William Camu, Mamede de Carvalho, Cristina Cereda, Hakan Cetin, Delia Chaverri, Adriano Chio, Philippe Corcia, Philippe Couratier, Fabiola De Marchi, Claude Desnuelle, Michael A Van Es, JesÚs Esteban, Massimiliano Mirabella, Alberto GarcÍa Redondo, Julian Grosskreutz, Clemens O Hanemann, Trygve HolmØy, Helle HØyer, Caroline Ingre, Blaz Koritnik, Magdalena Kuzma-Kozakiewicz, Thomas Lambert, Peter N Leigh, Christian Lunetta, Jessica Mandrioli, Christopher J McDermott, Thomas Meyer, Jesus S Mora, Susanne Petri, MÓnica Povedano, Evy Reviers, Nilo Riva, Kit C B Roes, Miguel Á Rubio, FranÇois Salachas, Stayko Sarafov, Gianni SorarÙ, Zorica Stevic, Kirsten Svenstrup, Anette Torvin MØller, Matthew C Kiernan, Philip Van Damme, Lucie A G Van Leeuwen, Luis Varona, Juan Francisco Vázquez Costa, Markus Weber, Orla Hardiman, Leonard H Van Den Berg
Clinical trials in pediatric ALS: a TRICALS feasibility study. Amyotrophic lateral sclerosis & frontotemporal degeneration 23 (7-8) (2022)
Emmanuel A Maze, Bora Agit, Shona Reeves, David A Hilton, David B Parkinson, Liyam Laraba, Emanuela Ercolano, Kathreena M Kurian, Clemens O Hanemann, Robert D Belshaw, Sylwia Ammoun
Human endogenous retrovirus type K promotes proliferation and confers sensitivity to anti-retroviral drugs in Merlin-negative schwannoma and meningioma. Cancer research (2021)
Agbolahan A Sofela, David A Hilton, Sylwia Ammoun, Daniele Baiz, Claire L Adams, Emanuela Ercolano, Michael D Jenkinson, Kathreena M Kurian, Mario Teo, Peter C Whitfield, Felix Sahm, Clemens O Hanemann
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas. International journal of molecular sciences 22 (2) (2021)
Chetan Bettegowda, Meena Upadhayaya, D Gareth Evans, Ae Rang Kim, Dimitrios Mathios, Clemens O Hanemann, null null
Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use. Neurology 97 (7 Suppl 1) (2021)
Jemma Dunn, Vasileios P Lenis, David A Hilton, Rolf Warta, Christel Herold-Mende, Clemens O Hanemann, Matthias E Futschik
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma. Cancers 12 (11) (2020)
Jade Lyons Rimmer, Emanuela Ercolano, Daniele Baiz, Mahindra Makhija, Allison Berger, Todd Sells, Steve Stroud, David Hilton, Claire L Adams, Clemens O Hanemann
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma. Cancers 12 (7) (2020)
Sara Ferluga, Daniele Baiz, David A Hilton, Claire L Adams, Emanuela Ercolano, Jemma Dunn, Kayleigh Bassiri, Kathreena M Kurian, Clemens O Hanemann
Constitutive activation of the EGFR-STAT1 axis increases proliferation of meningioma tumor cells. Neuro-oncology advances 2 (1) (2020)
Carolyn Anne Young, Roger Mills, Ammar Al-Chalabi, Georgina Burke, Siddharthan Chandran, David J Dick, John Ealing, Clemens O Hanemann, Timothy Harrower, Christopher J Mcdermott, Tahir Majeed, Ashwin Pinto, Kevin Talbot, Jannette Walsh, Timothy L Williams, Alan Tennant, null null
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotrophic lateral sclerosis & frontotemporal degeneration (2020)
Sylwia Ammoun, D Gareth Evans, David A Hilton, Adam J Streeter, Christopher Hayward, Clemens O Hanemann
Phase 0 trial investigating the intratumoural concentration and activity of sorafenib in neurofibromatosis type 2. Journal of neurology, neurosurgery, and psychiatry 90 (10) (2019)